Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
07:00am, Wednesday, 19'th May 2021
MINNEAPOLIS, May 19, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies Virtual Health
Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
07:00am, Tuesday, 18'th May 2021
MINNEAPOLIS, May 18, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a collaboration with Narayana Nethralaya to develop a diagnostic solution for ophthalmology disorders o
Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants Linked to Spinal Muscular Atrophy
07:00am, Monday, 10'th May 2021
MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Asuragen, a Bio-Techne brand, and scientific collaborators have published the results of a multisite
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q3 2021 Results - Earnings Call Transcript
02:12pm, Sunday, 09'th May 2021
Bio-Techne Corporation (TECH) CEO Chuck Kummeth on Q3 2021 Results - Earnings Call Transcript
Bio-Techne Releases Third Quarter Fiscal 2021 Results
06:30am, Thursday, 06'th May 2021
MINNEAPOLIS, May 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021. Third Quarter FY2021 Snapshot Third quar
Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards
02:20pm, Tuesday, 04'th May 2021
NEW YORK, May 4, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC, a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENX) (NASDAQ: RNLX), announced today that COVID-SeroKlir,
MINNEAPOLIS, April 27, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with r
MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in
Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development
07:00am, Wednesday, 14'th Apr 2021
MINNEAPOLIS, April 14, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage bi
Bio-Techne: Stealth M&A Play Looking Rich Here
12:17pm, Saturday, 10'th Apr 2021
Bio-Techne has been a steady value creator, operating largely under the radar of many investors. The company has combined organic growth with bolt-on M&A to establish this growth.
QGEN vs. TECH: Which Stock Should Value Investors Buy Now?
12:52pm, Thursday, 08'th Apr 2021
QGEN vs. TECH: Which Stock Is the Better Value Option?
Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
07:00am, Thursday, 08'th Apr 2021
MINNEAPOLIS, April 8, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system tha
Bio-Techne Completes Acquisition of Asuragen, Inc.
04:01pm, Tuesday, 06'th Apr 2021
MINNEAPOLIS, April 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc. The transaction included initial consideration of
Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results
07:00am, Tuesday, 06'th Apr 2021
MINNEAPOLIS, April 6, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, May 6, 2021, at 8:00 a.m. CDT to
Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures
07:00am, Monday, 29'th Mar 2021
MINNEAPOLIS, March 29, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of Cultrex™ UltiMatrix™ Reduced Growth Factor Basement Membrane Extract (RGF BME), an
